{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:05:09Z","timestamp":1790611509591,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.thromres.2006.12.006","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T16:02:37Z","timestamp":1170691357000},"page":"653-661","source":"Crossref","is-referenced-by-count":32,"title":["Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers"],"prefix":"10.1016","volume":"120","author":[{"given":"Majid","family":"Kalani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Blomb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Apelqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fagrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Torffvit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hamsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun","family":"J\u00f6rneskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2006.12.006_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.thromres.2006.12.006_bib2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.97.22.2213","article-title":"Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence","volume":"97","author":"Sobel","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.12.006_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/meta.2002.31334","article-title":"Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1","volume":"51","author":"Aso","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.thromres.2006.12.006_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000080884.27358.49","article-title":"Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease","volume":"108","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.12.006_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2796.1994.tb01104.x","article-title":"Diabetic foot ulcers in a multidisciplinary setting. An economical analysis of primary healing or healing with amputation","volume":"235","author":"Apelqvist","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.thromres.2006.12.006_bib6","unstructured":"Apelqvist J. Diabetic foot ulcers: the importance of clinical characteristics and prognostic factors for the outcome [dissertation]. Lund, Sweden: University of Lund; 1991."},{"key":"10.1016\/j.thromres.2006.12.006_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-5491.1995.tb02059.x","article-title":"Skin capillary circulation is more impaired in toes of diabetic than non-diabetic patients with peripheral vascular disease","volume":"12","author":"J\u00f6rneskog","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.thromres.2006.12.006_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.15.10.1245","article-title":"Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes","volume":"15","author":"Ganda","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2006.12.006_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s001250050607","article-title":"Altered properties of the fibrin gel structure in patients with IDDM","volume":"39","author":"J\u00f6rneskog","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.thromres.2006.12.006_bib10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2 diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"issue":"34","key":"10.1016\/j.thromres.2006.12.006_bib11","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1016\/S0021-9258(18)35759-4","article-title":"The effect of fibrin structure on fibrinolysis","volume":"267","author":"Gabriel","year":"1992","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.thromres.2006.12.006_bib12","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.thromres.2006.12.006_bib13","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/diacare.26.9.2575","article-title":"Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomised, double-blind and placebo-controlled study","volume":"26","author":"Kalani","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2006.12.006_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2796.2005.01562.x","article-title":"Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease","volume":"258","author":"Oldgren","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.thromres.2006.12.006_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/107110078100200202","article-title":"The dysvascular foot: a system for diagnosis and treatment","volume":"2","author":"Wagner","year":"1981","journal-title":"Foot Ankle"},{"key":"10.1016\/j.thromres.2006.12.006_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/ejvs.2002.1664","article-title":"A new automated toe blood pressure monitor for assessment of limb ischemia","volume":"24","author":"Wahlberg","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.thromres.2006.12.006_bib17","series-title":"Laser Doppler","first-page":"49","article-title":"Problems using laser Doppler on the skin in clinical practice","author":"Fagrell","year":"1994"},{"key":"10.1016\/j.thromres.2006.12.006_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF00418472","article-title":"Partional measurement of capillary and arteriovenous anastomotic blood flow in the human finger by laser Doppler flowmeter","volume":"57","author":"Hirata","year":"1988","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.thromres.2006.12.006_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1109\/TBME.1980.326582","article-title":"Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow","volume":"27","author":"Nilsson","year":"1980","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.thromres.2006.12.006_bib20","first-page":"367","article-title":"Biological zero in laser Doppler fluxmetry","volume":"7","author":"Caspary","year":"1988","journal-title":"Int J Microcirc Clin Exp"},{"key":"10.1016\/j.thromres.2006.12.006_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/00365517309082431","article-title":"Continuous transcutaneous oxygen measured with a heated electrode","volume":"31","author":"Huch","year":"1973","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.thromres.2006.12.006_bib22","first-page":"179","article-title":"Measuring tissue oxygen tension: a review","volume":"25","author":"Sheffield","year":"1998","journal-title":"Undersea Hyperb Med"},{"key":"10.1016\/j.thromres.2006.12.006_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0950-821X(88)80103-8","article-title":"Transcutaneous oxygen monitoring as an indication of prognosis in critical ischaemia of the lower limb","volume":"2","author":"Howd","year":"1988","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.thromres.2006.12.006_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diacare.22.1.147","article-title":"Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers","volume":"22","author":"Kalani","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2006.12.006_bib25","first-page":"220","article-title":"Oxygen inhalation-induced transcutaneous PO2 changes as a predictor of amputation level","volume":"2","author":"Harward","year":"1985","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.thromres.2006.12.006_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0741-5214(92)90196-F","article-title":"Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements","volume":"15","author":"Bacharach","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.thromres.2006.12.006_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1067\/mva.2001.115799","article-title":"Day-to-day variability of transcutaneous oxygen tension in patients with diabetes mellitus and peripheral arterial occlusive disease","volume":"34","author":"J\u00f6rneskog","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.thromres.2006.12.006_bib28","first-page":"415","article-title":"Purification of human and bovine fibrinogen","volume":"10","author":"Blomb\u00e4ck","year":"1956","journal-title":"Arkiv Kemi"},{"key":"10.1016\/j.thromres.2006.12.006_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0167-4838(89)90140-4","article-title":"Native fibrin gel networks observed by 3D microscopy, permeation and turbidity","volume":"997","author":"Blomb\u00e4ck","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.thromres.2006.12.006_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00043798-199704000-00005","article-title":"Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease","volume":"4","author":"Panahloo","year":"1997","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.thromres.2006.12.006_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0037-1613547","article-title":"Peripheral artery disease in type 2 diabetes: the role of fibrinolysis","volume":"89","author":"Lapolla","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.12.006_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0002-9149(94)90493-6","article-title":"Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women >or =62\u00a0years of age","volume":"74","author":"Aronow","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2006.12.006_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1358836X9900400301","article-title":"Disturbed microvascular reactivity and shunting \u2014 a major cause for diabetic complications","volume":"4","author":"Fagrell","year":"1999","journal-title":"Vasc Med"},{"key":"10.1016\/j.thromres.2006.12.006_bib34","doi-asserted-by":"crossref","unstructured":"Lowe GD. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2003 Sep-2004 Dec; 33: 455\u2013457.","DOI":"10.1159\/000083845"},{"key":"10.1016\/j.thromres.2006.12.006_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-8227(00)00134-0","article-title":"Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes","volume":"49","author":"Yamada","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.thromres.2006.12.006_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0049-3848(91)90347-Y","article-title":"Studies on fibrin network structure in human plasma. Part II \u2014 Clinical application: diabetes and antidiabetic drugs","volume":"64","author":"Nair","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.12.006_bib37","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1046\/j.1538-7836.2003.00301.x","article-title":"Increased plasma fibrin gel porosity in patients with type I diabetes during continuous subcutaneous insulin infusion","volume":"1","author":"J\u00f6rneskog","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.12.006_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0268-9499(98)80394-9","article-title":"Fibrin gel structure in diabetic patients before and during treatment with acetylsalicylic acid: a pilot study","volume":"12","author":"J\u00f6rneskog","year":"1998","journal-title":"Fibrinolysis Proteolysis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806005135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806005135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T11:20:25Z","timestamp":1628421625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384806005135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0049384806005135"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2006.12.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}